Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PrioR registry of pre-mixed CRRT solutions in critically ill adults
ChiCTR2500096865Phase 4Recruiting
- Sponsor
- Beijing Chaoyang Hospital
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Regiocit, Biphozyl and calcium chloride in acute kidney failure (AKF), sponsored by Beijing Chaoyang Hospital. Started Sep 2024; status: recruiting.
02
Drugs
RegiocitBiphozylcalcium chloride
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on ChiCTR2500096865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500096865.